HOME Top Market Reports Prefilled Syringes Market by Material (Glass, Plastic), Type (Conventional, Safety), Design (Dual & Single-Chamber, Customized ), Region (North America (U.S.), Europe (Germany, UK, France), Asia-Pacific (Japan, India, China)) - Forecast to 2021

Prefilled Syringes Market by Material (Glass, Plastic), Type (Conventional, Safety), Design (Dual & Single-Chamber, Customized ), Region (North America (U.S.), Europe (Germany, UK, France), Asia-Pacific (Japan, India, China)) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: November 2016
Report Code: MD 4755

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The prefilled syringes market is expected to reach USD 6.36 Billion by 2021 from USD 3.93 Billion in 2016, at a CAGR of 10.1% during the forecast period. Increasing prevalence of chronic diseases, technological advancements in prefilled syringes, large patient population base, and benefits associated with prefilled syringes are the major factors driving the growth of this market. In addition, growing initiatives undertaken by leading market players to establish production facilities in both mature and developing markets are further adding to the growth prospects of this market.

Emerging markets including China, India, South Africa, and the Middle East offer high growth potential for companies engaged in the development and distribution of prefilled syringes. Growing initiatives by market players, growing adoption of biosimilars/biologics, and the increasing prevalence of chronic diseases are the key factors propelling the growth of market in the emerging countries.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each product in emerging nations. The report provides qualitative insights about growth rates and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic region.

Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), and MedPro Inc. (U.S.) are some of the key players in the market.

Target Audience:

  • Prefilled Syringes Manufacturers, Suppliers, and Distributors
  • Biotechnology Companies
  • Hospitals
  • Clinical Centers
  • Pharmaceuticals Companies
  • Medical Research Laboratories
  • Consulting Firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the market into the following segments:

Global Prefilled Syringes Market, by Material

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

Global Prefilled Syringes Market, by Type

  • Conventional Prefilled Syringes
  • Safety Prefilled Syringes

Global Prefilled Syringes Market, by Design

  • Single-chamber
  • Dual-chamber
  • Customized

Global Prefilled Syringes Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the market

Table of Contents

1 Introduction (Page No. - 12)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 15)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation Methodology
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 23)

4 Premium Insights (Page No. - 27)
    4.1 Market Overview
    4.2 Market, By Material, 2016 vs 2021
    4.3 Market, By Type, 2016 vs 2021
    4.4 Market, By Region (2016 vs 2021)

5 Market Overview (Page No. - 29)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Technological Advancements
                    5.2.1.2 High Prevalence of Chronic Diseases
                    5.2.1.3 Benefits Associated With Prefilled Syringes
                               5.2.1.3.1 Benefits to Healthcare Professionals
                               5.2.1.3.2 Benefits to Patients
                               5.2.1.3.3 Benefits to Manufacturers
                    5.2.1.4 Rising Adoption of Self-Injection Devices
                    5.2.1.5 Implementation of Needlestick Legislations
                    5.2.1.6 Product Lifecycle Management Through Device Customization
           5.2.2 Restraints
                    5.2.2.1 Product Recalls
                    5.2.2.2 Low Market Presence of Prefilled Syringes With Integrated Safety Features
           5.2.3 Opportunities
                    5.2.3.1 Surge of Biologics and Biosimilar in the Pharmaceutical Market
                    5.2.3.2 Increasing Launch of Injectable Drugs in Prefilled Forms
           5.2.4 Challenges
                    5.2.4.1 Availability of Cheaper Alternatives
                    5.2.4.2 Challenges Associated With the Manufacturing of Prefilled Syringes

6 Prefilled Syringes Market, By Material (Page No. - 42)
    6.1 Introduction
    6.2 Glass Prefilled Syringes
    6.3 Plastic Prefilled Syringes

7 Prefilled Syringes Market, By Type (Page No. - 49)
    7.1 Introduction
    7.2 Conventional Prefilled Syringes
    7.3 Safety Prefilled Syringes

8 Prefilled Syringes Market, By Design (Page No. - 56)
    8.1 Introduction
    8.2 Single-Chamber Prefilled Syringes
    8.3 Dual-Chamber Prefilled Syringes
    8.4 Customized Prefilled Syringes

9 Prefilled Syringes Market, By Region (Page No. - 65)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 U.K.
           9.3.3 France
           9.3.4 Rest of Europe (RoE)
    9.4 Asia-Pacific
           9.4.1 China
           9.4.2 India
           9.4.3 Japan
           9.4.4 Rest of Asia-Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 93)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends
             10.3.1 Expansions
             10.3.2 Product Launches and Enhancements
             10.3.3 Acquisitions
             10.3.4 Partnerships
             10.3.5 Other Strategies

11 Company Profiles (Page No. - 100)
     11.1 Introduction
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*
     11.2 Gerresheimer AG
     11.3 Schott AG
     11.4 Becton, Dickinson and Company
     11.5 West Pharmaceutical Services, Inc.
     11.6 Vetter Pharma International GmbH
     11.7 Weigao Group
     11.8 OMPI (A Stevanato Group Company)
     11.9 Catalent, Inc.
     11.10 Nipro Corporation
     11.11 Medpro Inc.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 121)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (85 Tables)

Table 1 Prefilled Syringe Recalls, 2003-2015
Table 2 Indicative List of Medications Available in Prefilled Syringe Form
Table 3 Prefilled Syringes Market Size, By Material, 2014-2021 (USD Million)
Table 4 Glass Market Size, By Region, 2014-2021 (USD Million)
Table 5 North America: Glass Market Size, By Country, 2014-2021 (USD Million)
Table 6 Europe: Glass Market Size, By Country, 2014-2021 (USD Million)
Table 7 Asia-Pacific: Glass Market Size, By Country, 2014-2021 (USD Million)
Table 8 Plastic Market Size, By Region, 2014-2021 (USD Million)
Table 9 North America: Plastic Market Size, By Country, 2014-2021 (USD Million)
Table 10 Europe: Plastic Market Size, By Country, 2014-2021 (USD Million)
Table 11 Asia-Pacific: Plastic Market Size, By Country, 2014-2021 (USD Million)
Table 12 Market Size, By Type, 2014-2021 (USD Million)
Table 13 Conventional Market Size, By Region, 2014-2021 (USD Million)
Table 14 North America Conventional Market Size, By Country, 2014-2021 (USD Million)
Table 15 Europe: Conventional Market Size, By Country, 2014-2021 (USD Million)
Table 16 Asia-Pacific: Conventional Market Size, By Country, 2014-2021 (USD Million)
Table 17 Safety Market Size, By Region, 2014-2021 (USD Million)
Table 18 North America: Safety Market Size, By Country, 2014-2021 (USD Million)
Table 19 Europe: Safety Market Size, By Country, 2014-2021 (USD Million)
Table 20 Asia-Pacific: Safety Market Size, By Country, 2014-2021 (USD Million)
Table 21 Market Size, By Design, 2014-2021 (USD Million)
Table 22 Single-Chamber Market Size, By Region, 2014-2021 (USD Million)
Table 23 North America: Single-Chamber Market Size, By Country, 2014-2021 (USD Million)
Table 24 Europe: Single-Chamber Market Size, By Country, 2014-2021 (USD Million)
Table 25 Asia-Pacific: Single-Chamber Market Size, By Country, 2014-2021 (USD Million)
Table 26 Commercially Available for Lyophilized Drugs
Table 27 Dual-Chamber Market Size, By Region, 2014-2021 (USD Million)
Table 28 North America: Dual-Chamber Market Size, By Country, 2014-2021 (USD Million)
Table 29 Europe: Dual-Chamber Market Size, By Country, 2014-2021 (USD Million)
Table 30 Asia-Pacific: Dual-Chamber Market Size, By Country, 2014-2021 (USD Million)
Table 31 Customized Market Size, By Region, 2014-2021 (USD Million)
Table 32 North America: Customized Market Size, By Country, 2014-2021 (USD Million)
Table 33 Europe: Customized Market Size, By Country, 2014-2021 (USD Million)
Table 34 Asia-Pacific: Customized Market Size, By Country, 2014-2021 (USD Million)
Table 35 Market Size, By Region, 2014-2021 (USD Million)
Table 36 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 37 North America: Market Size, By Material, 2014-2021 (USD Million)
Table 38 North America: Market Size, By Design, 2014-2021 (USD Million)
Table 39 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 40 U.S.: Market Size, By Material, 2014-2021 (USD Million)
Table 41 U.S.: Market Size, By Design, 2014-2021 (USD Million)
Table 42 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 43 Canada: Market Size, By Material, 2014-2021 (USD Million)
Table 44 Canada: Market Size, By Design, 2014-2021 (USD Million)
Table 45 Canada: Market Size, By Type, 2014-2021 (USD Million)
Table 46 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 47 Europe: Market Size, By Material, 2014-2021 (USD Million)
Table 48 Europe: Market Size, By Design, 2014-2021 (USD Million)
Table 49 Europe: Market Size, By Type, 2014-2021 (USD Million)
Table 50 Germany: Market Size, By Material, 2014-2021 (USD Million)
Table 51 Germany: Market Size, By Design, 2014-2021 (USD Million)
Table 52 Germany: Market Size, By Type, 2014-2021 (USD Million)
Table 53 U.K.: Market Size, By Material, 2014-2021 (USD Million)
Table 54 U.K.: Market Size, By Design, 2014-2021 (USD Million)
Table 55 U.K.: Market Size, By Type, 2014-2021 (USD Million)
Table 56 France: Market Size, By Material, 2014-2021 (USD Million)
Table 57 France: Market Size, By Design, 2014-2021 (USD Million)
Table 58 France: Market Size, By Type, 2014-2021 (USD Million)
Table 59 RoE: Market Size, By Material, 2014-2021 (USD Million)
Table 60 RoE: Market Size, By Design, 2014-2021 (USD Million)
Table 61 RoE: Market Size, By Type, 2014-2021 (USD Million)
Table 62 Asia-Pacific: Market Size, By Country, 2014-2021 (USD Million)
Table 63 Asia-Pacific: Market Size, By Material, 2014-2021 (USD Million)
Table 64 Asia-Pacific: Market Size, By Design, 2014-2021 (USD Million)
Table 65 Asia-Pacific: Market Size, By Type, 2014-2021 (USD Million)
Table 66 China: Market Size, By Material, 2014-2021 (USD Million)
Table 67 China: Market Size, By Design, 2014-2021 (USD Million)
Table 68 China: Market Size, By Type, 2014-2021 (USD Million)
Table 69 India: Market Size, By Material, 2014-2021 (USD Million)
Table 70 India: Market Size, By Design, 2014-2021 (USD Million)
Table 71 India: Market Size, By Type, 2014-2021 (USD Million)
Table 72 Japan: Market Size, By Material, 2014-2021 (USD Million)
Table 73 Japan: Market Size, By Design, 2014-2021 (USD Million)
Table 74 Japan: Market Size, By Type, 2014-2021 (USD Million)
Table 75 Rest of Asia-Pacific: Market Size, By Material, 2014-2021 (USD Million)
Table 76 Rest of Asia-Pacific: Market Size, By Design, 2014-2021 (USD Million)
Table 77 Rest of Asia-Pacific: Market Size, By Type, 2014-2021 (USD Million)
Table 78 RoW: Market Size, By Material, 2014-2021 (USD Million)
Table 79 RoW: Market Size, By Design, 2014-2021 (USD Million)
Table 80 RoW: Market Size, By Type, 2014-2021 (USD Million)
Table 81 Expansions, 2013–2016
Table 82 Product Launches and Enhancements, 2013–2016
Table 83 Acquisitions, 2013-2016
Table 84 Partnerships, 2013–2016
Table 85 Other Strategies, 2013-2016


List of Figures (41 Figures)

Figure 1 Prefilled Syringes Market Segmentation
Figure 2 Global Market: Research Methodology Steps
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Design
Figure 5 Data Triangulation Methodology
Figure 6 Global Prefilled Syringes Market, By Material, 2016 vs 2021 (USD Billion)
Figure 7 Global Prefilled Syringes Market, By Type, 2016 vs 2021 (USD Billion)
Figure 8 Global Prefilled Syringes Market, By Design, 2016 vs 2021 (USD Billion)
Figure 9 Europe to Command the Largest Share of the Global Market
Figure 10 Technological Advancements and High Prevalence of Chronic Diseases are Key Drivers for the Market
Figure 11 Plastic Prefilled Syringes to Register the Highest CAGR in the Forecast Period
Figure 12 Conventional Prefilled Syringes to Dominate the Market in 2016
Figure 13 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 14 Prefilled Syringes Market: Drivers, Restraints, Opportunities, & Challenges
Figure 15 Estimated Number of Diabetic Patients, By Region, 2015 vs 2040
Figure 16 Percentage Increase in the Number of New Cancer Cases, By Country (2012 vs 2020)
Figure 17 Plastic Prefilled Syringes Segment to Witness Highest Growth During the Forecast Period
Figure 18 Europe to Dominate in the Glass Prefilled Syringes Market
Figure 19 Asia-Pacific to Dominate the Plastic Prefilled Syringes Market During the Forecast Period
Figure 20 Conventional Prefilled Syringes Segment to Dominate the Market During the Forecast Period
Figure 21 Europe to Dominate the Conventional Prefilled Syringes Market
Figure 22 Europe to Command the Largest Share in the Safety Prefilled Syringes Market
Figure 23 Dual-Chamber Syringes to Witness Highest Growth During the Forecast Period
Figure 24 Europe Holds the Largest Share in the Single-Chamber Prefilled Syringes Market
Figure 25 Europe Holds the Largest Share in the Dual-Chamber Prefilled Syringes Market
Figure 26 Europe Holds the Largest Share in the Customized Prefilled Syringes Market
Figure 27 Prefilled Syringes Market Size, By Region, 2016 vs 2021
Figure 28 North America: Prefilled Syringes Market Snapshot
Figure 29 Europe: Prefilled Syringes Market Snapshot
Figure 30 Asia-Pacific: Prefilled Syringes Market Snapshot
Figure 31 Leading Market Players Adopted Expansions and Product Launches as Their Key Growth Strategy From 2013 to 2016
Figure 32 Global Prefilled Syringes Market Share, By Key Player, 2015
Figure 33 Expansions Was the Key Growth Strategy Pursued By Market Players Between 2013 & 2016
Figure 34 Geographic Revenue Mix of the Top Three Players
Figure 35 Company Snapshot: Gerresheimer AG
Figure 36 Company Snapshot: Schott AG
Figure 37 Company Snapshot: Becton, Dickinson and Company
Figure 38 Company Snapshot: West Pharmaceutical Services, Inc.
Figure 39 Company Snapshot: Weigao Group
Figure 40 Company Snapshot: Catalent, Inc.
Figure 41 Company Snapshot: Nipro Corporation

The global prefilled syringes market is projected to reach USD 6.36 Billion by 2021 from USD 3.93 Billion in 2016, growing at a CAGR of 10.1% between 2016 and 2021. The rising demand for prefilled syringes can be attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and implementation of needlestick legislations. In addition, growing awareness on the benefits of prefilled syringes among patients and healthcare professionals, along with the growing number of biologics and biosimilars in the pharmaceuticals market is supporting the growth of the market.

On the basis of material, the market is segmented into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment is expected to account for the largest of the market in 2016. The growth of this segment can be attributed to the high use of glass in manufacturing syringes owing to its nonreactive nature and heat and chemical resistance.

On the basis of type, the market is categorized into conventional prefilled syringes and safety prefilled syringes. The conventional prefilled syringes segment is expected to account for the largest share of the market in 2016. The increasing adoption of self-administered injectable drugs, rising prevalence of chronic diseases, and the benefits offered by prefilled syringes over traditional vial syringe systems are the key factors responsible for the growth of this segment.

On the basis of design, the market is segmented into single-chamber, dual-chamber, and customized prefilled syringes. The single-chamber prefilled syringes segment is expected to account for the largest share of the market in 2016. The increasing adoption of self-administered parental drugs and rising prevalence of chronic diseases are the key factors driving the growth of this segment.

On the basis of region, the market is segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, Europe is estimated to dominate the global market. Factors such as the rising prevalence of chronic diseases, growth in the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, rising aging population, and high adoption of self-injection devices are driving the growth in the European market. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. The increasing demand for self-administered treatments and high penetration of self-injection devices, growing aging population, increasing prevalence of diabetes, and huge patient population are the major factors driving market growth in the region.

Prefilled Syringes Market

Expansions and product launches were the primary growth strategies adopted by major players to expand their product portfolio in the global prefilled syringes market. Several market players also adopted strategies such as acquisitions and partnerships to expand their presence and increase their visibility in the market. Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany). Nipro Corporation (Japan), and MedPro Inc. (U.S.) are some of the key players operating in the global market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Drug Delivery Devices Markets on KnowledgeStore
Request Demo